Triggering Receptor Expressed on Myeloid Cells‐2 Expression Tracks With M2‐Like Macrophage Activity and Disease Severity in COPD

[1]  A. Fagan,et al.  Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status , 2016, Acta Neuropathologica.

[2]  M. Colonna,et al.  TREM-2 promotes macrophage survival and lung disease after respiratory viral infection , 2015, The Journal of experimental medicine.

[3]  Jianping Zhao,et al.  Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation. , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[4]  M. Colonna,et al.  OSCAR Is a Receptor for Surfactant Protein D That Activates TNF-α Release from Human CCR2+ Inflammatory Monocytes , 2015, The Journal of Immunology.

[5]  J. Fahy.  Type 2 inflammation in asthma — present in most, absent in many , 2014, Nature Reviews Immunology.

[6]  Xinyu Wang,et al.  The role of airway epithelial cells and innate immune cells in chronic respiratory disease , 2014, Nature Reviews Immunology.

[7]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[8]  L. Edwards,et al.  Lessons from ECLIPSE: a review of COPD biomarkers , 2013, Thorax.

[9]  R. Pierce,et al.  Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. , 2013, The Journal of clinical investigation.

[10]  A. Condliffe,et al.  The neutrophil in chronic obstructive pulmonary disease. , 2013, American journal of respiratory cell and molecular biology.

[11]  M. Holtzman,et al.  IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. , 2012, The Journal of clinical investigation.

[12]  M. Holtzman.  Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. , 2012, The Journal of clinical investigation.

[13]  M. Holtzman,et al.  Alternatively activated macrophages and airway disease. , 2011, Chest.

[14]  G. Rohde,et al.  Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 1 in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease , 2011, Respiration.

[15]  L. Lanier,et al.  DAP12 Is Required for Macrophage Recruitment to the Lung in Response to Cigarette Smoke and Chemotaxis toward CCL2 , 2010, The Journal of Immunology.

[16]  R. Pierce,et al.  Macrophage chitinase 1 stratifies chronic obstructive lung disease. , 2009, American journal of respiratory cell and molecular biology.

[17]  Ronald G. Crystal,et al.  Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease1 , 2009, The Journal of Immunology.

[18]  Jiyong Jing,et al.  Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis , 2009, Intensive Care Medicine.

[19]  O. Sharif,et al.  From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. , 2008, Immunobiology.

[20]  R. Schmidt,et al.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. , 2008, Brain : a journal of neurology.

[21]  Jeffrey D. Morton,et al.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease , 2008, Nature Medicine.

[22]  S. Tenzer,et al.  Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease , 2007, Clinical & developmental immunology.

[23]  T. Lim,et al.  Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections , 2006, European Respiratory Journal.

[24]  L. Piccio,et al.  Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.

[25]  Jeffrey D. Morton,et al.  Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. , 2006, The Journal of clinical investigation.

[26]  Y. H. Yang,et al.  A distinctive alveolar macrophage activation state induced by cigarette smoking. , 2005, American journal of respiratory and critical care medicine.

[27]  P. Bollaert,et al.  Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis , 2004, Annals of Internal Medicine.

[28]  M. Béné,et al.  Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. , 2004, The New England journal of medicine.

[29]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.